Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Clynes

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
British Journal of Cancer|October 27, 2004
A new superinvasive in vitro phenotype induced by selection of human breast carcinoma cells with the chemotherapeutic drugs paclitaxel and doxorubicinS A Glynn, P Gammell, M Heenan, et al.
The British Journal of Ophthalmology|November 1, 1996
Multidrug resistance in ocular melanomaM McNamara, M Clynes, B Dunne, et al.
Journal of Biotechnology|December 21, 2010
Engineering CHO cell growth and recombinant protein productivity by overexpression of miR-7N Barron, N Kumar, N Sanchez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 22, 2010
Inhibition of IGF1R activity enhances response to trastuzumab in HER-2-positive breast cancer cellsB C Browne, J Crown, N Venkatesan, et al.
Hybridoma and Hybridomics|February 13, 2002
A new monoclonal antibody, P2A8(6), that specifically recognizes a novel epitope on the multidrug resistance-associated protein 1 (MRP1), but not on MRP2 nor MRP3L Connolly, E Moran, A Larkin, et al.
Anticancer Research|June 28, 2007
Purification and identification of a 7.6-kDa protein in media conditioned by superinvasive cancer cellsP Dowling, P Maurya, P Meleady, et al.
The Journal of Pharmacy and Pharmacology|July 3, 2004
Synthesis of (2E)-2-methyl-3-(4-([4-(quinolin-2-ylmethoxy)phenyl]sulfanyl)phenyl)prop-2-enoic acid (VUFB 20609) and 2-methyl-3-(4-([4-(quinolin-2-ylmethoxy)phenyl]sulfanyl)phenyl)propanoic acid (VUFB 20584) as potential antileukotrienic agentsJ Jampílek, M Dolezal, J Kunes, et al.
Cytotechnology|January 1, 1996
Absence of correlation between chemo- and radioresistance in a range of human tumour cell linesM Heenan, K Kavanagh, A Redmond, et al.
European Journal of Cancer (Oxford, England : 1990)|October 13, 2009
MiRNA-29a regulates the expression of numerous proteins and reduces the invasiveness and proliferation of human carcinoma cell linesM K Muniyappa, P Dowling, M Henry, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 25, 2009
TMEM25, REPS2 and Meis 1: favourable prognostic and predictive biomarkers for breast cancerP Doolan, M Clynes, S Kennedy, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
British Journal of Cancer|October 27, 2004
A new superinvasive in vitro phenotype induced by selection of human breast carcinoma cells with the chemotherapeutic drugs paclitaxel and doxorubicinS A Glynn, P Gammell, M Heenan, et al.
The British Journal of Ophthalmology|November 1, 1996
Multidrug resistance in ocular melanomaM McNamara, M Clynes, B Dunne, et al.
Journal of Biotechnology|December 21, 2010
Engineering CHO cell growth and recombinant protein productivity by overexpression of miR-7N Barron, N Kumar, N Sanchez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 22, 2010
Inhibition of IGF1R activity enhances response to trastuzumab in HER-2-positive breast cancer cellsB C Browne, J Crown, N Venkatesan, et al.
Hybridoma and Hybridomics|February 13, 2002
A new monoclonal antibody, P2A8(6), that specifically recognizes a novel epitope on the multidrug resistance-associated protein 1 (MRP1), but not on MRP2 nor MRP3L Connolly, E Moran, A Larkin, et al.
Anticancer Research|June 28, 2007
Purification and identification of a 7.6-kDa protein in media conditioned by superinvasive cancer cellsP Dowling, P Maurya, P Meleady, et al.
The Journal of Pharmacy and Pharmacology|July 3, 2004
Synthesis of (2E)-2-methyl-3-(4-([4-(quinolin-2-ylmethoxy)phenyl]sulfanyl)phenyl)prop-2-enoic acid (VUFB 20609) and 2-methyl-3-(4-([4-(quinolin-2-ylmethoxy)phenyl]sulfanyl)phenyl)propanoic acid (VUFB 20584) as potential antileukotrienic agentsJ Jampílek, M Dolezal, J Kunes, et al.
Cytotechnology|January 1, 1996
Absence of correlation between chemo- and radioresistance in a range of human tumour cell linesM Heenan, K Kavanagh, A Redmond, et al.
European Journal of Cancer (Oxford, England : 1990)|October 13, 2009
MiRNA-29a regulates the expression of numerous proteins and reduces the invasiveness and proliferation of human carcinoma cell linesM K Muniyappa, P Dowling, M Henry, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 25, 2009
TMEM25, REPS2 and Meis 1: favourable prognostic and predictive biomarkers for breast cancerP Doolan, M Clynes, S Kennedy, et al.
Pageof 10